NVUS | Novus Therapeutics Inc. Analyst Estimates | MarketWatch Jun 06, 2020 NVUS: Novus Therapeutics Inc - Stock Price, Quote ... - CNBC Get Novus Therapeutics Inc (NVUS:NASDAQ) real-time stock quotes, news and financial information from CNBC.
NVUS on StockCharts.com Novus Therapeutics, Inc., formerly Tokai Pharmaceuticals, Inc., is a pharmaceutical company. The Company is focused on the acquisition, development, and … NVUS Stock Price & Charts | Novus Therapeutics
Hedge Funds Watching Novus Therapeutics, Inc. (NVUS) From Afar: May 15: Novus Therapeutics EPS misses by $0.31: May 15: Novus Therapeutics Reports First Quarter 2020 Financial Results: May 12: 3 Biotech Stocks Under $3 With 200%-Plus Upside Potential: Apr 7: We're A Little Worried About Novus Therapeutics's (NASDAQ:NVUS) Cash Burn Rate: Mar 26
Novus Therapeutics, Inc., a pharmaceutical company, focuses on developing products for patients with disorders of ear, nose, and throat. Its lead product is (OP-02), a surfactant-based combination drug product for patients at risk for, or with, otitis media (OM) (middle ear inflammation with or without infection). Vislink Technologies, Inc. VISL 0.95 0.04 (4.18%). NASDAQ Updated Jun 9, 2020 8:06 AM BIO-key International, Inc. BKYI 0.94 0.08 (9.79%). NASDAQ Updated Jun 8, 2020 11:02 PM Join Stocktwits for free stock discussions, prices, and market sentiment with millions of investors and traders. Stocktwits is the largest social network for finance. J. C. Penney Company, Inc. JCP 0.63 0.31 (95.90%). OTC Updated Jun 8, 2020 7:59 PM
Jun 05, 2020 NVUS - Seeking Alpha From an enhanced free experience to professional stock picking - we have a great plan for you $NVUS Stock Technical Analysis | Novus | SwingTradeBot.com